Literature DB >> 27320905

The perceptions of Australian oncologists about cognitive changes in cancer survivors.

Kate Smidt1, Lynette Mackenzie2, Haryana Dhillon3, Janette Vardy4, Joanne Lewis5, Siew Yim Loh6.   

Abstract

OBJECTIVE: Cancer-related cognitive changes (CRCC) can have a profound impact on a cancer survivor's quality of life. However, cancer survivors frequently report receiving limited information about their experience of CRCC from their oncology specialists. This qualitative study aimed to explore the perceptions of oncology specialists regarding CRCC and the potential for their views to influence their decisions about patient care.
METHODS: Thirteen medical oncologists and five radiation oncologists currently practising in Australia participated in this study. Data collection involved individual semi-structured interviews via telephone. Data were audio-recorded, transcribed verbatim and analysed using a thematic approach.
RESULTS: Four key themes emerged: (1) beliefs about the impact of priming on cancer survivors' perceived cognitive function, (2) perceptions of who is more likely to raise concerns of cognitive change, (3) uncertainty of how to best manage CRCC, and (4) the perceived role of oncologists in the management of CRCC.
CONCLUSIONS: CRCC and its impact on the cancer survivor's journey have been under-addressed by oncology specialists, and they are uncertain of potential management strategies. With cancer survival rates increasing, there is a need for specific interventions and management guidelines addressing CRCC and their effects on cancer survivors. Future exploration should focus on the survivor as central to their care and holistic approaches to CRCC management involving all members of the multidisciplinary team.

Entities:  

Keywords:  Cancer; Clinical practice; Cognition; Oncology; Qualitative; Survivorship

Mesh:

Year:  2016        PMID: 27320905     DOI: 10.1007/s00520-016-3315-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  31 in total

1.  Cancer as a chronic disease.

Authors:  Jane Louise Phillips; David C Currow
Journal:  Collegian       Date:  2010       Impact factor: 2.573

Review 2.  Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations.

Authors:  Audrey Jusko Friedman; Roxanne Cosby; Susan Boyko; Jane Hatton-Bauer; Gale Turnbull
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

Review 3.  'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study.

Authors:  T Mitchell; P Turton
Journal:  Eur J Cancer Care (Engl)       Date:  2011-03-28       Impact factor: 2.520

4.  Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.

Authors:  Kerstin Hermelink; Michael Untch; Michael P Lux; Rolf Kreienberg; Thomas Beck; Ingo Bauerfeind; Karin Münzel
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

Review 5.  Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.

Authors:  Thomas W McAllister; Tim A Ahles; Andrew J Saykin; Robert J Ferguson; Brenna C McDonald; Lionel D Lewis; Laura A Flashman; C Harker Rhodes
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

6.  Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.

Authors:  Stephanie A Reid-Arndt; Albert Yee; Michael C Perry; Catherine Hsieh
Journal:  J Psychosoc Oncol       Date:  2009

7.  Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

Authors:  J Vardy; J S Wefel; T Ahles; I F Tannock; S B Schagen
Journal:  Ann Oncol       Date:  2007-10-31       Impact factor: 32.976

Review 8.  Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review.

Authors:  Saskia F A Duijts; Martine P van Egmond; Evelien Spelten; Peter van Muijen; Johannes R Anema; Allard J van der Beek
Journal:  Psychooncology       Date:  2013-12-23       Impact factor: 3.894

9.  Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.

Authors:  Maryam Hafsah Selamat; Siew Yim Loh; Lynette Mackenzie; Janette Vardy
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

10.  Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.

Authors:  Nelli Boykoff; Mona Moieni; Saskia Karen Subramanian
Journal:  J Cancer Surviv       Date:  2009-09-16       Impact factor: 4.442

View more
  5 in total

1.  Cancer-related cognitive impairment: a mixed methods evaluation of a standard factsheet.

Authors:  Chloe Yi Shing Lim; Sharon He; Joanne Shaw; Haryana M Dhillon
Journal:  Support Care Cancer       Date:  2021-11-06       Impact factor: 3.603

2.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

3.  Cognitive complaints in cancer survivors and expectations for support: Results from a web-based survey.

Authors:  Marie Lange; Idlir Licaj; Bénédicte Clarisse; Xavier Humbert; Jean-Michel Grellard; Laure Tron; Florence Joly
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.452

4.  Australian oncology health professionals' knowledge, perceptions, and clinical practice related to cancer-related cognitive impairment and utility of a factsheet.

Authors:  Sharon He; Chloe Yi Shing Lim; Haryana M Dhillon; Joanne Shaw
Journal:  Support Care Cancer       Date:  2022-02-05       Impact factor: 3.359

5.  Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer.

Authors:  Vladimir Druel; Laetitia Gimenez; Kim Paricaud; Jean-Pierre Delord; Pascale Grosclaude; Nathalie Boussier; Marie-Eve Rougé Bugat
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.